Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 17, 2019
Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patientsKhaled Elsayad, Gabriele Reinartz, Michael Oertel, et al.
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS)Martin Benesch, Ivo Leuschner, Eva Wardelmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGISTAgnieszka Wozniak, Piotr Rutkowski, Patrick Schöffski, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 17, 2019
Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patientsKhaled Elsayad, Gabriele Reinartz, Michael Oertel, et al.
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS)Martin Benesch, Ivo Leuschner, Eva Wardelmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGISTAgnieszka Wozniak, Piotr Rutkowski, Patrick Schöffski, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Pageof 25